Search Results
May 20, 2026, 10:00 ET UPSHER-SMITH LAUNCHES GENERIC VERSION OF RESTASIS® (CYCLOSPORINE OPHTHALMIC EMULSION 0.05%)
partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients' quality of life.By investing in talent, infrastructure,
More news about: Upsher-Smith Laboratories, LLC
May 20, 2026, 09:34 ET Haier Signs Four-Year Sponsorship with Al Ahly FC, Becoming the Club's Second Main Sponsor
provider of better life and digital transformation solutions, with the purpose of "More Creation, More Possibilities." The company has established 10 R&D centers, 35 industrial parks, and 173 manufacturing centers, achieving a global revenue of USD 59.8 billion in 2025. Haier has been ranked in the Kantar
More news about: Haier
May 20, 2026, 09:20 ET Haier Signs Four-Year Sponsorship with Al Ahly FC, Becoming the Club's Second Main Sponsor
provider of better life and digital transformation solutions, with the purpose of "More Creation, More Possibilities." The company has established 10 R&D centers, 35 industrial parks, and 173 manufacturing centers, achieving a global revenue of USD 59.8 billion in 2025. Haier has been ranked in the Kantar
More news about: Haier
May 20, 2026, 09:12 ET Casper Ruud powraca do Sztokholmu, podczas gdy Bybit EU rozszerza działalność w krajach nordyckich
SZTOKHOLM, 20 maja 2026 r. /PRNewswire/ -- Casper Ruud powraca na
More news about: Bybit
May 20, 2026, 09:00 ET Benchling and Baseten Partner to Bring AI Inference to Biotech R&D
28 to more than 380. These models are now standard in R&D workflows, but the compute layer hasn't kept up. Drug discovery is bursty by nature: teams wait on the physical lab, data comes in waves, then need
More news about: Benchling
May 20, 2026, 09:00 ET RGC Deadline Alert: Levi & Korsinsky Reminds Regencell Bioscience Holdings (RGC) Investors of Securities Class Action Deadline on June 23, 2026
Market Manipulation VulnerabilityRegencell is an early-stage bioscience company with twelve employees, no approved products, no revenue, and R&D spending of roughly $1 million per year. Yet the Company's market value reached approximately $14 billion. As The Wall Street Journal observed, only
More news about: Levi & Korsinsky, LLP
May 20, 2026, 08:53 ET PHNIX a présenté ses innovations en matière de systèmes CVC pilotés par l'IA au salon MCE Milan 2026
Au cours de l'événement, PHNIX a organisé une conférence de lancement de produits qui a fait date, mettant en avant son écosystème de pompes à chaleur R290 polyvalent. Il s'agissait de présenter en première mondiale la pompe à chaleur domestique air/eau GreenTherm Pro et la pompe à chaleur intérieure monobloc
More news about: PHNIX
May 20, 2026, 08:52 ET PHNIX präsentierte auf der MCE Milan 2026 KI-gestützte Innovationen im Bereich HLK
Im Rahmen der Veranstaltung veranstaltete PHNIX eine wegweisende Produktvorstellung, bei der das All-Scenario-R290-Wärmepumpen-Ökosystem im Mittelpunkt stand. Im Rahmen der Präsentation wurden die Luft-Wasser-Wärmepumpe „GreenTherm Pro" für Privathaushalte und die
More news about: PHNIX
May 20, 2026, 08:49 ET PHNIX presentó su innovación en sistemas HVAC impulsada por IA en MCE Milan 2026
Durante el evento, PHNIX organizó una trascendental Conferencia de Presentación de Productos, donde destacó su ecosistema de bombas de calor R290 para todo tipo de escenarios. La presentación incluyó el debut mundial de la bomba de calor residencial aire-agua GreenTherm Pro y la bomba de calor
More news about: PHNIX
May 20, 2026, 08:32 ET PNK Group Begins Construction on 1 Million SF Industrial Facility in Griffin, Georgia
185-foot truck court, 245 trailer parking, and 480 car parking spaces.Distinctive features of PNK Group buildings include:R-25 enhanced roof insulation;A 30-year roof membrane warranty;Three-layer insulated reinforced concrete walls.
More news about: PNK Group
May 20, 2026, 08:08 ET Eisai Deepens Body of Clinical Evidence for LENVIMA (Lenvatinib) Across Established Indications at ASCO 2026
Concept], we aim to effectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet
More news about: Eisai Inc.
May 20, 2026, 08:03 ET Podczas Miesiąca Świadomości Zdrowia Psychicznego NCCN potwierdza swoje zaangażowanie na rzecz rozwoju zasobów łagodzących cierpienie psychiczne związane z chorobami nowotworowymi
bezpłatnie w ponad 70 językach.PLYMOUTH MEETING (Pensylwania), 20 maja 2026 r. /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) - sojusz czołowych ośrodków leczenia nowotworów w USA - ogłasza,
More news about: National Comprehensive Cancer Network
May 20, 2026, 08:00 ET MetaVia Highlights Peer-Reviewed Publication Supporting the Anti-Fibrotic Potential of Vanoglipel in MASH
DA-1726 is a novel oxyntomodulin (OXM) analogue that functions as a glucagon-like peptide-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist. OXM is a naturally-occurring gut hormone that activates GLP1R and GCGR, thereby decreasing food intake while increasing energy expenditure, thus potentially
More news about: MetaVia Inc.
May 20, 2026, 08:00 ET KING'S HAWAIIAN ANNOUNCES PARTNERSHIP & NEW LIMITED EDITION SHAKE 'EM" BANANA BITES WITH ILLUMINATION'S MINIONS & MONSTERS
[email protected] King's Hawaiian®Founded 75 years ago in Hilo, Hawaii, by Robert R. Taira, KING'S HAWAIIAN is a family-owned business that has been dedicated to providing Hawaii-inspired foods made with original recipes
More news about: King's Hawaiian
May 20, 2026, 07:00 ET Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility
leadership roles at Merck, Sigma-Aldrich Millipore, including VP of Engineering and Process Development, where he oversaw engineering, manufacturing, R&D, and operational activities across multiple sites in Israel, Europe, and the United States. His experience includes management of multidisciplinary
More news about: Scinai Immunotherapeutics Ltd.
May 20, 2026, 07:00 ET Evogene Reports First Quarter 2026 Financial Results
period of 2025, representing a decrease of approximately $0.7 million. The decrease is mainly attributable to lower R&D expenses in Biomica, Casterra, and AgPlenus. The decrease in R&D expenses attributable to Evogene and its subsidiaries was substantially offset by the impact of exchange rate fluctuations
More news about: Evogene
May 20, 2026, 06:45 ET Canon Demonstrates Print's 'Power to Move' With On-Stand Experience and Latest Large Format Technologies at FESPA Global Print Expo 2026
its environmental impact and supporting customers to reduce theirs using Canon's products, solutions and services. Canon invests heavily in R&D, delivering the richest and most innovative products and services to satisfy customers' creative needs. From amateur photographers to professional
More news about: Canon Middle East
May 20, 2026, 06:20 ET Knoll debiutuje z systemem biurowym Konzert, w którym precyzja idzie ramię w ramię z możliwościami
wyrafinowanych i zintegrowanych przestrzeni biurowych.LONDYN, 20 maja 2026 r. /PRNewswire/ -- Knoll prezentuje Konzert, harmonijny system biurowy zaprojektowany przez włoskiego architekta i projektanta, Paolo Dell'Elce, w ramach
More news about: Knoll
May 20, 2026, 06:11 ET Singapore Deepens AI Ecosystem with Global Collaborators to Accelerate Real-World Deployment
and deploy them on enterprise projects including financial services and precision health.A*STAR Institute for Infocomm Research (A*STAR I2R) is updating the MERaLiON (Multimodal Empathetic Reasoning and Learning in One Network) AI Model to advance capabilities, drive real-world use cases,
More news about: Infocomm Media Development Authority of Singapore
May 20, 2026, 06:03 ET TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM's incentive program
https://news.cision.com/torm-plc/r/torm-plc-capital-increase-in-connection-with-exercise-of-restricted-share-units-as-part-of-torm-s-in,c4350759The following files are available for download:
More news about: Torm PLC
May 20, 2026, 06:01 ET Seeker Labs Announces BlueRock Therapeutics as Anchor Tenant at Catalyst
reinforces the continued demand for institutional-grade life sciences infrastructure in Toronto."Since its founding in 2016, BlueRock has maintained R&D and manufacturing operations in Toronto. Today it is a wholly owned, independently operated subsidiary of Bayer AG, focused on developing cell therapies
More news about: Seeker
May 20, 2026, 06:01 ET Seeker Labs Announces BlueRock Therapeutics as Anchor Tenant at Catalyst
reinforces the continued demand for institutional-grade life sciences infrastructure in Toronto."Since its founding in 2016, BlueRock has maintained R&D and manufacturing operations in Toronto. Today it is a wholly owned, independently operated subsidiary of Bayer AG, focused on developing cell therapies
More news about: Seeker
May 20, 2026, 06:00 ET Palmetto Appoints Loren Padelford as President, Consumer Energy
appointment of Loren Padelford as President, Consumer Energy. In this role, Padelford will lead Palmetto's consumer growth strategy - including platform R&D, full funnel consumer marketing, partnerships and customer support - as the company accelerates its mission to make energy simple and affordable for
More news about: Palmetto Clean Technology, Inc.